ClinicalTrials.Veeva

Menu

An Investigation of the Past 10 Yrs Health Care for Primary Care Patients With Chronic Obstructive Pulmonary Disease (PATHOS)

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease

Study type

Observational

Funder types

Industry

Identifiers

NCT01146392
NIS-RSE-DUM-2010/1

Details and patient eligibility

About

The aim of this study is to describe COPD health care and to assess demographics, concurrent diseases and mortality and the use of pharmaceuticals for a chronic obstructive pulmonary disease (COPD) population in real life in primary care during the last ten years.

Enrollment

27,394 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • COPD diagnosis according to medical records.
  • Use of drugs prescribed for obstructive lung diseases

Trial design

27,394 participants in 1 patient group

1
Description:
Primary care patients with COPD diagnosis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems